JMCP has added two prominent academic health care researchers to its editorial team, a move designed to keep pace with the growing influence of AMCP’s peer-reviewed, scientific journal.

AMCP has released Version 4.1 of the AMCP Format for Formulary Submissions, which includes two new dossier types for biopharmaceutical manufacturers to share evidence on unapproved products and new indications that are under review by the U.S. Food and Drug Administration (FDA).

Increased simplicity, broader financial risk sharing, and an enhanced focus on patient care were among the recommendations developed by diverse stakeholders at a recent AMCP Partnership Forum focused on how to better manage the high costs of specialty medications.

National Harbor, Md., Oct. 29, 2019 — AMCP Nexus 2019 will welcome nearly 2,500 managed care pharmacy professionals from across the country this week for four days of educational and networking programs focused on the “intersection of value and care.”

AMCP announced today that Phil Bongiorno has joined the organization as vice president, policy & government relations. In this role, he will oversee AMCP’s many advocacy efforts to advance managed care pharmacy principles and practices through health care legislation and regulation at both the federal and state levels.

AMCP last week gathered a group of diverse health care stakeholders to discuss the challenges and opportunities of ensuring patient access to a category of emerging therapies known as “digital therapeutics,” which have the potential to treat a wide range of diseases and medical conditions.

Press Release: AMCP comments in joint statement on the Administration’s latest initiative to modernize substance use disorder (SUD) treatment privacy law and enhance coordinated care and safety.